Unknown

Dataset Information

0

MiR-139-5p regulates proliferation, apoptosis, and cell cycle of uterine leiomyoma cells by targeting TPD52.


ABSTRACT: BACKGROUND:Uterine leiomyoma is one of the most common benign tumors in women. It dramatically decreases the quality of life in the affected women. However, there is a lack of effective treatment paradigms. Micro-RNAs are small noncoding RNA molecules that are extensively expressed in organisms, and they are interrelated with the occurrence and development of the tumor. miR-139-5p was found to be downregulated in various cancers, but its function and mechanism in uterine leiomyoma remain unknown. The aim of this study was to investigate the role of miR-139-5p and its target gene in uterine leiomyoma. METHODS:By using a bioinformatic assay, it was found that TPD52 was a potential target gene of miR-139-5p. Then, expressions of miR-139-5p and TPD52 in uterine leiomyoma and adjacent myometrium tissues were evaluated by quantitative real-time polymerase chain reaction and Western blot. Proliferation, apoptosis, and cell cycle of uterine leiomyoma cells transfected by miR-139-5p mimics or TPD52 siRNA were determined. RESULTS:It was observed that the expression of miR-139-5p in uterine leiomyoma tissues was significantly lower (P<0.001) than that in the adjacent myometrium tissues. Overexpression of miR-139-5p inhibited the growth of uterine leiomyoma cells and induced apoptosis and G1 phase arrest. Dual-luciferase reporter assay and Western blot validated that TPD52 is the target gene of miR-139-5p. Furthermore, downregulation of TPD52 by siRNA in uterine leiomyoma cells inhibited cell proliferation and induced cell apoptosis and G1 phase arrest. CONCLUSION:Data suggested that miR-139-5p inhibited the proliferation of uterine leiomyoma cells and induced cell apoptosis and G1 phase arrest by targeting TPD52.

SUBMITTER: Chen H 

PROVIDER: S-EPMC5067016 | biostudies-literature | 2016

REPOSITORIES: biostudies-literature

altmetric image

Publications

miR-139-5p regulates proliferation, apoptosis, and cell cycle of uterine leiomyoma cells by targeting TPD52.

Chen Hong H   Xu Hong H   Meng Yu-Gang YG   Zhang Yun Y   Chen Jun-Ying JY   Wei Xiao-Ning XN  

OncoTargets and therapy 20161011


<h4>Background</h4>Uterine leiomyoma is one of the most common benign tumors in women. It dramatically decreases the quality of life in the affected women. However, there is a lack of effective treatment paradigms. Micro-RNAs are small noncoding RNA molecules that are extensively expressed in organisms, and they are interrelated with the occurrence and development of the tumor. miR-139-5p was found to be downregulated in various cancers, but its function and mechanism in uterine leiomyoma remain  ...[more]

Similar Datasets

| S-EPMC8130534 | biostudies-literature
| S-EPMC8064781 | biostudies-literature
| S-EPMC9253409 | biostudies-literature
| S-EPMC4741860 | biostudies-literature
| S-EPMC5021030 | biostudies-literature
| S-EPMC9578823 | biostudies-literature
| S-EPMC7460735 | biostudies-literature
| S-EPMC9846112 | biostudies-literature
| S-EPMC5920642 | biostudies-literature
| S-EPMC9704413 | biostudies-literature